Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RSV monoclonal antibody
- Development stage
- Preclinical
- Lead developer
- Changchun BCHT Biotechnology
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intramuscular
01
Overview
RSV monoclonal antibody is a monoclonal antibody candidate in preclinical development by Changchun BCHT Pharmaceutical for the prevention and treatment of respiratory syncytial virus (RSV) infection. The antibody is designed to neutralize the virus, thereby preventing it from infecting host cells in the respiratory tract. This therapeutic approach aims to provide passive immunity or treat active infections, particularly in vulnerable populations such as infants and the elderly. It is part of BCHT's pipeline of antibody and vaccine products targeting infectious diseases.
- Brand names
- SynagisBeyfortus
- Other names
- 呼吸道合胞病毒RSV单克隆抗体RSV Monoclonal Antibodyrespiratory syncytial virus monoclonal antibody
02
Targets
RSV F (Respiratory syncytial virus fusion protein)
Beyond the preview
Go deeper on RSV monoclonal antibody.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RSV monoclonal antibody.